Spacelabs Healthcare, Inc., headquartered in the United States, is a leading provider in the medical technology industry, specialising in innovative patient monitoring and diagnostic solutions. Founded in 1958, the company has established a strong presence in key operational regions, including North America, Europe, and Asia-Pacific. With a focus on advanced telemetry, anaesthesia delivery systems, and cloud-based data management, Spacelabs Healthcare distinguishes itself through its commitment to enhancing patient care and safety. The company’s core products, such as the Qube™ patient monitoring system, are designed to integrate seamlessly into clinical workflows, providing real-time data to healthcare professionals. Recognised for its dedication to quality and innovation, Spacelabs Healthcare has achieved significant milestones, positioning itself as a trusted partner in healthcare settings worldwide. Its reputation for reliability and cutting-edge technology continues to drive its success in the competitive medical device market.
How does Spacelabs Healthcare, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Spacelabs Healthcare, Inc.'s score of 35 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Spacelabs Healthcare, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of OSI Systems, Inc., which may influence its climate-related initiatives and reporting. While there are no documented reduction targets or climate pledges from Spacelabs Healthcare, it is important to note that emissions data and performance metrics may be inherited from its parent company, OSI Systems, Inc. This relationship suggests that any climate commitments or emissions reductions may align with the broader strategies of OSI Systems, Inc., although specific details are not provided. As of now, Spacelabs Healthcare has not established any publicly available science-based targets or commitments to reduce emissions, which places it in a context where many companies are increasingly focusing on sustainability and climate action. The lack of specific emissions data and reduction initiatives highlights an opportunity for Spacelabs Healthcare to enhance its environmental responsibility and transparency in the future.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2024 | |
|---|---|---|
| Scope 1 | 10,060,000 | 0,000,000 |
| Scope 2 | 17,856,000 | 00,000,000 |
| Scope 3 | 2,700,000 | 0,000,000 |
Spacelabs Healthcare, Inc.'s Scope 3 emissions, which increased by 78% last year and increased by approximately 78% since 2022, demonstrating supply chain emissions tracking. Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 19% of total emissions under the GHG Protocol, with "Business Travel" representing nearly all of their reported Scope 3 footprint.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Spacelabs Healthcare, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.